CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
54 research outputs found
Utilization of Glycoprotein IIB/IIIA Receptor Antagonists in the Management of Acute Coronary Syndrome: Focus on Patient Characteristics and Formulary Decisions
Author
Braunwald E.
Braunwald E.
+14Â more
Grundy S.M.
O'Shea J.C.
Simoons ML
Tcheng J.E.
The CAPTURE investigators.
The EPIC investigators.
The EPILOG investigators.
The EPISTENT investigators.
The IMPACT II investigators.
The PRISM investigators.
The PRISM-PLUS investigators.
The PURSUIT trial investigators.
The RESTORE investigators.
Theroux P.
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
Retrospective, Observational Comparison of Eptifibatide vs Abciximab in Patients Undergoing Percutaneous Coronary Intervention
Author
EPIC Investigators.
Gold H.K.
+15Â more
Labinaz M.
O'Shea J.C.
PRISM Study Investigators.
PRISM-PLUS Investigators.
Scweiger M.J.
Sulieman M.
Tcheng J.E.
The CAPTURE Investigators.
The EPILOG Investigators.
The EPISTENT Investigators.
The ESPRIT Investigators.
The IMPACT-II Investigators.
The PURSUIT trial Investigators.
The RESTORE Investigators.
Topol E.J.
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
ReoPro rules: results from the ‘Do Tirofiban and ReoPro Give Similar Efficacy Trial’ (TARGET)
Author
MICKELSON JK
NEUMANN FJ
+8Â more
PLATELET RECEPTOR INHIBITION IN ISCHEMIC SYNDROME MANAGEMENT
RAO AK
Sheila A Doggrell
THE EPIC INVESTIGATORS
THE EPILOG INVESTIGATORS
THE EPISTENT INVESTIGATORS
THE RESTORE INVESTIGATORS
TOPOL EJ
Publication venue
'Informa Healthcare'
Publication date
Field of study
No full text
Crossref
Glycoprotein IIb/IIIa inhibitors: More different than alike?
Author
Abdelmeguid
Anderson
+23Â more
Brener
Califf
Cannon
Cox
EPISTENT Investigators
IMPACT-II Investigators
Kereiakes
Kereiakes
Lage
Lefkovits
Liu
Mehran
Stone
Tcheng
Tcheng
The CAPTURE Investigators
The EPIC Investigators
The EPILOG Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The RESTORE Investigators
Topol
Willerson
Publication venue
'Wiley'
Publication date
01/01/2001
Field of study
No full text
Crossref
Thrombocytopenia complicating treatment with intravenous glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis
Author
Bednar
Berkowitz
+28Â more
Berkowitz
Carolin M. Frey
Coller
Elmi
Ferrari
Francis J. Menapace
Frelinger
G.Craig Wood
Gart
Himadri Dasgupta
James C. Blankenship
Jenkins
Jordan
Joseph
Jubelirer
Kereiakes
Mendes
Peter
S.Lee Demko
The CAPTURE investigators
The EPIC investigators
The EPIC study group
The EPILOG investigators
The IMPACT-II investigators
The PRISM study investigators
The PRISM-PLUS study investigators
The PURSUIT trial investigators
The RESTORE investigators
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
Learning from the Recently Completed Oral Glycoprotein IIb/IIIa Receptor Antagonist Trials
Author
Ault
Cannon
+18Â more
Cannon
Cannon
CAPTURE Investigators
Cox
EPIC Investigators
EPILOG Investigators
Holmes
Kong
Langer
Moussa
O'Neill
Peter
The IMPACT-II Investigators
The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
The PURSUIT Trial Investigators
The RESTORE Investigators
The SYMPHONY Investigators
Topol
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Evaluation on the safety and efficacy of tirofiban in the treatment of acute coronary syndrome
Author
E. Boersma
G. W. Stone
+6Â more
J. E. Tcheng
J. H. Kim
M. A. Crouch
The PRISM-PLUS Study Investigators.
The RESTORE investigators.
Yu’e Song
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
No full text
Crossref
Efficacy and Safety of Tirofiban in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes
Author
Braunwald
Danzi
+14Â more
De Queiroz Fernandes Arau
Hartman
Lincoff
Lynch
Madan
Montalescot
Okmen
PRISM-PLUS Study Investigators
RESTORE Investigators
Teirstein
The PRISM Study Investigators
Valgimigli
Willerson
Zhang
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Cost Efficacy of Platelet Glycoprotein IIb/IIIa Antagonists in Clinical Trials and Clinical Practice
Author
Coller BS
Ezratty AM
+6Â more
Lincoff AM
Mark DB
Mark DB
Mark DB
Steinhubl SR
The RESTORE investigators.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Optimizing Antiplatelet Therapy in Coronary Interventions
Author
Antiplatelet Trialists' Collaboration
Berger
+29Â more
Bertrand
CAPRIE Steering Committee
Detre
EPIC Investigators
EPILOG Investigators
EPISTENT Investigators
Gent
Gent
Harker
Harker
Kereiakes
Leon
Lincoff
Lincoff
Moussa
O'Neill
Savcic
Schömig
Steele
Steinhubl
Steinhubl
Tam
The CAPTURE Investigators
The IMPACT-II Investigators
The RESTORE Investigators
Thornton
Théroux
Topol
Topol
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
1
2
3
…
last